財華社集團(08317.HK):擬5800萬港元向主席出售東亞銀行港灣中心物業
格隆匯8月13日丨財華社集團(08317.HK)宣佈,於2021年8月13日,公司間接全資附屬源利置業作為賣方與公司主席、執行董事兼控股股東勞玉儀作為買方訂立臨時協議,勞玉儀擬向源利置業購買萬誠管理100%股權及承讓銷售債務,代價約為5800萬港元(可予調整)。
出售公司主要從事投資控股,由賣方全資擁有,並由公司間接全資擁有。出售公司的主要資產為該物業,總實用面積約為1755平方尺,位於香港東亞銀行港灣中心11樓C室。該物業目前為空置。
集團預期錄得出售事項收益淨額約780萬港元,公司擬將出售事項的所得款項淨額用於補充集團的營運資金及未來業務發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.